Mike John Dinsdale bought $100k of PWRL
Chief Executive Officer at Powerlaw Corp.. 8,726 shares at an average of $11.46, traded Sep 23, 2026, filed Sep 24, 2026.
Score components
- +25RoleCEO
- +10Trade size$100k at market
- 0Relative to holdingsHoldings up 1.3%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-26-103178, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | POpen-market purchase Common Stock, par value $0.001 per shareindirect: By Michael John Dinsdale 2015 Trust | +8,726 | $11.46 | $100k | 695,230 | 20 d ago |
Related signals
Other insiders at Powerlaw Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 51Moderate | Powerlaw Corp. | Benjamin David Black Chief Investment Officer | $101k 6,500 shares | +1% | |
| 64Notable | Powerlaw Corp. | Mike John Dinsdale Chief Executive Officer | $246k 15,668 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.